Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The sharp rally comes as the newly listed company reported a strong Q1 FY27 performance, swinging to a profit of Rs 58.75 crore from a loss in the year-ago quarter.
Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?
Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from ...
By Dhallo News · September 10, 2026 at 12:19 PM IST
Source: Economic Times - Forex
SOURCE: Economic Times - Forex
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion